ACL Reconstruction With/Without ALL Reconstruction

Last updated: July 13, 2022
Sponsor: Centre of Postgraduate Medical Education
Overall Status: Active - Recruiting

Phase

N/A

Condition

Lymphocytic Leukemia, Acute

Treatment

N/A

Clinical Study ID

NCT05461625
ACL_ALL
  • Ages 18-65
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This study will compare Anterior Cruciate Reconstruction with or without Anterolateral Ligament Reconstruction in patients with ACL injury. The purpose of this study is evaluate if addition of ALLr to ACLr provides better clinical, radiological and laboratory outcomes.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • primary ACL injury

Exclusion

Exclusion Criteria:

  • no informed consent to participate in the study
  • age under 18 years or above 65
  • multilligament injury or single plane knee instability (medial, lateral)
  • another musculoskeletal disorders in lower limb
  • lower limb deformity requiring axis correction below 4o or above 12.5o
  • joints inflammatory diseases
  • ASA score > II

Study Design

Total Participants: 762
Study Start date:
September 01, 2021
Estimated Completion Date:
December 01, 2024

Study Description

This study compare ACL reconstruction and additional tenodesis or ALL recontruction described by Arnold. Patients will be randomized fot this tree group and surgeon will be blinded.

Anterolateral ligament reconstruction could play a role in augmenting rotational stability in the ACL-reconstructed knee and are most likely to benefit hyperlax patients, revision cases, pivoting athletes, and those with IKDC grade III pivot shifts. In our study we will would like to confirm this hypothesis.

Connect with a study center

  • Department of Orthopaedics and Traumatology, Centre of Postgraduate Medical Education, Professor A. Gruca Teaching Hospital

    Otwock, Mazowieckie 05-400
    Poland

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.